Immix Biopharma
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11400 W Olympic Blvd, Los Angeles, Calif...Phone Number
(310) 651-8041Website
www.immixbio.comRevenue
<$5 MillionStock Symbol
IMMXIndustry
About Immix Biopharma
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.Explore more
SIC Code 87,873NAICS Code 54,541Ticker NASDAQ: IMMXShow moreImmix Biopharma Org Chart
Compare Similar Companies to Immix Biopharma
Compare insights from companies similar to Immix Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immix Biopharma Tech Stack
A closer look at the technologies used by Immix Biopharma
Top Business Services Companies
Frequently Asked Questions Regarding Immix Biopharma
Sign Up For FreeTo access detailed company insights
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 fo... Read More